Evidence map›Paper›PMID 36466880›Full record

ReviewFrontiers in immunology2022

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management.

Kai R Plunkett, Jesse D Armitage, Andrisha-Jade Inderjeeth, Alison M McDonnell, Jason Waithman, Peter K H Lau

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. CD8 + T Cells in Gastrointestinal Cancer: a Perspective on Targeting MicroRNA.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  7. Targeting tumor metabolism to augment CD8Journal of pharmaceutical analysis · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kai R PlunkettSchool of Biomedical Sciences, University of Western Australia, Nedlands, WA, Australia.
Jesse D ArmitageSchool of Biomedical Sciences, University of Western Australia, Nedlands, WA, Australia.
Andrisha-Jade InderjeethDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Alison M McDonnellTelethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Jason WaithmanSchool of Biomedical Sciences, University of Western Australia, Nedlands, WA, Australia.
Peter K H LauMelanoma Discovery Laboratory, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.
The Kids Research Institute Australia · AUHarry Perkins Institute of Medical Research · AUPeter MacCallum Cancer Centre · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue-resident memory T (T

Indexed as

MelanomaMemory T CellsCD8-Positive T-LymphocytesCTLA-4 AntigenHumansProgrammed Cell Death 1 ReceptorCTLA-4 AntigenProgrammed Cell Death 1 Receptoradjuvant immunotherapycancer immunotherapyimmune checkpointsmelanomaneoadjuvant immunotherapytissue-resident memory CD8(+) T cellstumor microenvironment

Identifiers

PMID36466880
PMCPMC9709277
OpenAlexW4309310353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.